The public-private NEXT Partnership is working to make Denmark the pharmaceutical industry’s first choice for clinical trials. Clinical trials are conducted to ensure the safety and efficacy of new pharmaceutical products before they can be approved by regulatory authorities.
In order to shed light on the benefits of conducting clinical trials, NEXT Partnership, The Danish Association of the Pharmaceutical Industry and Invest in Denmark asked Copenhagen Economics to quantify the value generated by clinical trials in Denmark.
The main conclusions of the study are:
The study is commissioned by NEXT Partnership, The Danish Association of the Pharmaceutical Industry and Invest in Denmark.Download